Toru Oka

6.6k total citations
126 papers, 4.4k citations indexed

About

Toru Oka is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Toru Oka has authored 126 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 49 papers in Cardiology and Cardiovascular Medicine and 28 papers in Surgery. Recurrent topics in Toru Oka's work include Congenital heart defects research (18 papers), Cardiac Fibrosis and Remodeling (13 papers) and Chemotherapy-induced cardiotoxicity and mitigation (12 papers). Toru Oka is often cited by papers focused on Congenital heart defects research (18 papers), Cardiac Fibrosis and Remodeling (13 papers) and Chemotherapy-induced cardiotoxicity and mitigation (12 papers). Toru Oka collaborates with scholars based in Japan, United States and Germany. Toru Oka's co-authors include Issei Komuro, Jeffery D. Molkentin, Hiroshi Akazawa, Atsuhiko T. Naito, Jian Xu, Bruce J. Aronow, Yoshio Yazaki, Mikio Mukai, Ichiro Shiojima and Yukio Hiroi and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Toru Oka

122 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toru Oka Japan 32 2.6k 1.9k 879 471 384 126 4.4k
Stefan E. Hardt Germany 32 2.1k 0.8× 1.8k 1.0× 711 0.8× 317 0.7× 467 1.2× 91 4.2k
W. Matthijs Blankesteijn Netherlands 32 2.2k 0.8× 1.6k 0.9× 815 0.9× 487 1.0× 225 0.6× 80 4.0k
Djamel Lebeche United States 34 2.8k 1.1× 1.9k 1.0× 1.1k 1.2× 273 0.6× 476 1.2× 80 4.7k
José Vilar France 38 2.1k 0.8× 1.0k 0.5× 540 0.6× 334 0.7× 342 0.9× 89 4.3k
John J. Lepore United States 38 2.4k 0.9× 1.3k 0.7× 841 1.0× 481 1.0× 947 2.5× 61 4.7k
Burns C. Blaxall United States 43 3.6k 1.4× 3.2k 1.7× 879 1.0× 616 1.3× 490 1.3× 88 6.3k
Martin G. Sirois Canada 38 1.6k 0.6× 1.2k 0.7× 564 0.6× 414 0.9× 350 0.9× 125 4.0k
Koichiro Kuwahara Japan 47 2.9k 1.1× 3.1k 1.7× 988 1.1× 526 1.1× 531 1.4× 218 6.3k
Micheline Duriez France 38 2.4k 0.9× 1.4k 0.8× 1.3k 1.4× 456 1.0× 347 0.9× 59 5.6k
Mark Aronovitz United States 37 2.1k 0.8× 2.3k 1.2× 809 0.9× 333 0.7× 414 1.1× 98 5.5k

Countries citing papers authored by Toru Oka

Since Specialization
Citations

This map shows the geographic impact of Toru Oka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Oka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Oka more than expected).

Fields of papers citing papers by Toru Oka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Oka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Oka. The network helps show where Toru Oka may publish in the future.

Co-authorship network of co-authors of Toru Oka

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Oka. A scholar is included among the top collaborators of Toru Oka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Oka. Toru Oka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nishikawa, Tatsuya, Yoshihiko Ikeda, Keiko Ohta‐Ogo, et al.. (2023). Tenascin-C as a potential marker for immunohistopathology of doxorubicin-induced cardiomyopathy. European Heart Journal Open. 3(5). oead104–oead104.
2.
Ng, Choon Ta, Li Ling Tan, Il Suk Sohn, et al.. (2022). Advancing Cardio-Oncology in Asia. Korean Circulation Journal. 53(2). 69–69. 4 indexed citations
3.
Yasui, Taku, Wataru Shioyama, Toru Oka, et al.. (2020). Acute myocardial infarction caused by tumor embolus originating from upper tract urothelial carcinoma: a case report. Cardio-Oncology. 6(1). 18–18.
4.
Oka, Toru, Hiroshi Akazawa, Kazuhiro Sase, Kiyohiko Hatake, & Issei Komuro. (2020). Cardio-Oncology in Japan. JACC CardioOncology. 2(5). 815–818. 7 indexed citations
5.
Kunimasa, Kei, Toru Oka, Makiko Oboshi, et al.. (2020). Cardiac Adverse Events in EGFR-Mutated Non-Small Cell Lung Cancer Treated With Osimertinib. JACC CardioOncology. 2(1). 1–10. 58 indexed citations
6.
Kunimasa, Kei, Toru Oka, Satoshi Hara, et al.. (2020). Osimertinib is associated with reversible and dose-independent cancer therapy-related cardiac dysfunction. Lung Cancer. 153. 186–192. 24 indexed citations
7.
Yasui, Taku, Wataru Shioyama, Makiko Oboshi, et al.. (2020). Coronary spastic angina in a multiple myeloma patient treated with bortezomib, lenalidomide, and dexamethasone. Journal of Cardiology Cases. 21(5). 197–199. 2 indexed citations
8.
Shioyama, Wataru, Toru Oka, Taku Yasui, & Masashi Fujita. (2019). Single-drug approach with rivaroxaban: A case of successful anticoagulation against cancer-associated thrombosis. Journal of Cardiology Cases. 20(2). 39–41. 2 indexed citations
9.
Mukai, Mikio & Toru Oka. (2018). Mechanism and management of cancer-associated thrombosis. Journal of Cardiology. 72(2). 89–93. 131 indexed citations
10.
Yasui, Taku, Takeshi Masaki, Yoh Arita, et al.. (2016). Molecular Characterization of Striated Muscle-Specific Gab1 Isoform as a Critical Signal Transducer for Neuregulin-1/ErbB Signaling in Cardiomyocytes. PLoS ONE. 11(11). e0166710–e0166710. 4 indexed citations
11.
Lee, Jong-Kook, Akira Yoshida, Hiroyuki Nakanishi, et al.. (2014). Excitation propagation in three-dimensional engineered hearts using decellularized extracellular matrix. Biomaterials. 35(27). 7839–7850. 40 indexed citations
12.
Nakatani, Kazuhiro, Daisaku Masuda, Toru Oka, et al.. (2013). Abstract 12900: Pressure Overload Induces Hypertrophy and Impaired Cardiac Function in Long-chain Fatty Acid Transporter CD36 Knockout Mice. Circulation. 128. 1 indexed citations
13.
Ueda, Kazutaka, Hiroyuki Takano, Yuriko Niitsuma, et al.. (2010). Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice. Journal of Clinical Investigation. 120(6). 2016–2029. 66 indexed citations
14.
Oka, Toru & Issei Komuro. (2008). Molecular Mechanisms Underlying the Transition of Cardiac Hypertrophy to Heart Failure(Molecular Mechanisms). Japanese Circulation Journal-english Edition. 72. 1 indexed citations
15.
Okada, Hisayuki, et al.. (2000). [Multi-vasospastic angina refractory to medical therapy caused by hyperthyroid stage of chronic thyroiditis and hypereosinophilia: a case report].. PubMed. 35(3). 189–96. 6 indexed citations
16.
Wakimoto, Koji, Kinji Kobayashi, Makoto Kuro‐o, et al.. (2000). Targeted Disruption of Na+/Ca2+ Exchanger Gene Leads to Cardiomyocyte Apoptosis and Defects in Heartbeat. Journal of Biological Chemistry. 275(47). 36991–36998. 179 indexed citations
17.
Sakurai, Toshihiro, et al.. (1999). Serum lipids status in patients with diabetic uremia on 10 years of maintenance hemodialysis. Kidney International. 56. S216–S218. 2 indexed citations
18.
Shiojima, Ichiro, Issei Komuro, Toru Oka, et al.. (1999). Context-dependent Transcriptional Cooperation Mediated by Cardiac Transcription Factors Csx/Nkx-2.5 and GATA-4. Journal of Biological Chemistry. 274(12). 8231–8239. 103 indexed citations
19.
Shiojima, Ichiro, Issei Komuro, Toru Oka, et al.. (1998). IS003 Transcriptional Regulation of Human Cardiac Homeobox Gene CSX1-Role of Bone Morphogenetic Proteins and Downstream Signaling Molecules. Japanese Circulation Journal-english Edition. 62. 13. 1 indexed citations
20.
Tani, Satoshi, Makoto Otsuki, Hiroshi Itoh, et al.. (1987). Histologic and biochemical alterations in experimental acute pancreatitis induced by supramaximal caerulein stimulation. International Journal of Pancreatology. 2(5-6). 337–348. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefan E. Hardt Breakdown of academic impact, for papers by W. Matthijs Blankesteijn Breakdown of academic impact, for papers by Djamel Lebeche Breakdown of academic impact, for papers by José Vilar Breakdown of academic impact, for papers by John J. Lepore Breakdown of academic impact, for papers by Burns C. Blaxall Breakdown of academic impact, for papers by Martin G. Sirois Breakdown of academic impact, for papers by Koichiro Kuwahara Breakdown of academic impact, for papers by Micheline Duriez Breakdown of academic impact, for papers by Mark Aronovitz
Rankless by CCL
2026